|Videos|April 20, 2022
The Top 3 Technological Challenges in Decentralized Trials
Author(s)IQVIA
Nagaraja Srivatsan, SVP & Chief Digital Officer at IQVIA, breaks down the most recent challenges in the decentralized trial space: patient burden, the ecosystem between the patient and information, and the global regulatory landscape.
- The harmony of decentralized trials is when site, sponsor, and patient come together.
- There is no one size fits all for technological adaptations when it comes to the patient.
- Regulations for data flow, GDPR, patient privacy, and more are constantly coming in, and must be adhered to.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
3
New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup
4
ACT Brief: FDA’s Agentic AI Rollout, Exercise Interventions for Long COVID, and Patient-Centered Evidence Beyond the Trial
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
